We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Optimizing Antibody Drug Development With Machine Learning

News   Apr 16, 2021 | Original story from ETH Zurich

 
Optimizing Antibody Drug Development With Machine Learning

Machine learning helps develop optimal antibody drugs. Credit: ETH Zurich

 
 
Advertisement
 

RELATED ARTICLES

Study Finds COVID-19 Vaccines Do Not Damage the Placenta in Pregnancy

News

A new Northwestern Medicine study of placentas from patients who received the COVID-19 vaccine during pregnancy found no evidence of injury, adding to the growing literature that COVID-19 vaccines are safe in pregnancy.

READ MORE

New Class of Cancer Fighting Compounds Discovered

News

A new class of anti-cancer compounds that effectively kill liver and breast cancer cells has been discovered by scientists.

READ MORE

Dual Vaccination Prevents Allergic Asthma in New Mouse Study

News

Promising results in a mouse model could point the way to the development of a therapy to treat half of all asthma cases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE